Brainstorm Cell Therapeutics, Inc. (BCLI)
0.98
-0.08
(-7.55%)
USD |
OTCM |
Aug 21, 16:00
Brainstorm Cell Therapeutics Total Assets (Quarterly) : 0.788M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.788M |
| March 31, 2026 | 0.755M |
| December 31, 2025 | 1.022M |
| September 30, 2025 | 1.38M |
| June 30, 2025 | 2.566M |
| March 31, 2025 | 3.571M |
| December 31, 2024 | 1.832M |
| September 30, 2024 | 2.025M |
| June 30, 2024 | 5.683M |
| March 31, 2024 | 3.348M |
| December 31, 2023 | 4.208M |
| September 30, 2023 | 5.682M |
| June 30, 2023 | 5.747M |
| March 31, 2023 | 7.872M |
| December 31, 2022 | 8.451M |
| September 30, 2022 | 13.25M |
| June 30, 2022 | 18.96M |
| March 31, 2022 | 25.79M |
| December 31, 2021 | 29.28M |
| September 30, 2021 | 34.54M |
| June 30, 2021 | 42.24M |
| March 31, 2021 | 48.57M |
| December 31, 2020 | 51.26M |
| September 30, 2020 | 32.69M |
| June 30, 2020 | 19.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 18.07M |
| December 31, 2019 | 6.534M |
| September 30, 2019 | 7.811M |
| June 30, 2019 | 8.864M |
| March 31, 2019 | 11.85M |
| December 31, 2018 | 11.23M |
| September 30, 2018 | 13.77M |
| June 30, 2018 | 21.02M |
| March 31, 2018 | 9.413M |
| December 31, 2017 | 11.42M |
| September 30, 2017 | 11.34M |
| June 30, 2017 | 8.001M |
| March 31, 2017 | 9.032M |
| December 31, 2016 | 10.77M |
| September 30, 2016 | 11.72M |
| June 30, 2016 | 13.15M |
| March 31, 2016 | 13.81M |
| December 31, 2015 | 17.08M |
| September 30, 2015 | 18.36M |
| June 30, 2015 | 20.36M |
| March 31, 2015 | 22.39M |
| December 31, 2014 | 9.911M |
| September 30, 2014 | 11.40M |
| June 30, 2014 | 12.52M |
| March 31, 2014 | 4.193M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0647M |
| Summit Therapeutics, Inc. | 752.18M |
| Kezar Life Sciences, Inc. | 68.00M |
| Protara Therapeutics, Inc. | 176.09M |
| Clene, Inc. | 23.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.38M |
| Shareholders Equity (Quarterly) | -11.60M |
| Debt to Equity Ratio | -0.1185 |
| Current Ratio | 0.0255 |
| Net Debt Paydown Yield | 0.72% |